{"nct_id":"NCT02835690","title":"Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Pembrolizumab (MK-3475) in Chinese Participants With Non-Small-Cell Lung Cancer (MK-3475-032/KEYNOTE-032)","status":"COMPLETED","status_verified_date":"2022-09","start_date":"2016-08-04","start_date_type":"ACTUAL","primary_completion_date":"2017-09-19","primary_completion_date_type":"ACTUAL","completion_date":"2021-12-31","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}